# Mangoceuticals, Inc.: Form SCHEDULE 13D/A, filed Sep 30, 2025

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-30
- Accepted by EDGAR: Sep 30, 2025, 16:59 ET
- Period: not reported
- Accession: 0001493152-25-016353
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225016353/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000149315225016353/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000149315225016353/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-016353. Last ingested by Listed: Nov 6, 2026, 18:28 ET. No prices; not investment advice.
